Catheter repair for leaky mitral valve in heart failure
Part of Heart & circulation clinical trials.
This trial tests a new device (CathHELIX) placed through a vein to repair a leaky mitral valve in people with heart failure. It is for people with moderate to severe mitral regurgitation who still have symptoms despite medical therapy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have moderate to severe or severe functional mitral regurgitation (a leaky heart valve)
- Your heart's pumping strength is 30% or higher
- You have symptoms like shortness of breath or fatigue (NYHA class II to IV)
- You do not need oxygen at home for lung disease
- You have not had a heart transplant
- Your mitral valve and coronary vein anatomy are suitable for the device
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new device called the MRace implant that is designed to repair a leaky mitral valve without open-heart surgery. It may help people with severe leakage who are at high risk for traditional surgery.
This trial tests a new device that is placed using a thin tube through a vein in the leg to repair a leaky mitral valve in people with heart failure. The goal is to see if it can reduce symptoms and improve quality of life beyond what usual medications can do.
This trial tests a new device to fix a leaky mitral valve in people with moderate to severe leakage who are too high-risk for open-heart surgery. It aims to improve heart function and symptoms.
This trial tests a new device designed to fix a leaky mitral valve in people with heart failure. It may help you breathe easier and feel less tired if your valve leak is severe and medicines have not been enough.
This trial studies a new way to replace a damaged mitral heart valve using a catheter (a thin tube), instead of open-heart surgery. It may help people who have severe leaking of the mitral valve but are considered too high-risk for surgery.
This trial tests a new device for people whose mitral valve leaks badly (grade 3+ or 4+) and who are not candidates for surgery. The device aims to fix the leak through a less invasive approach, and the study checks if it's safe and works well in daily life.
Hear when a new Mitral Valve Regurgitation (Degenerative or Functional) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.